Journey Medical DERM
NASDAQ DERM
$5.09 +0.29 (+6.04%)
At close: Oct 22, 2026 · 4:00 PM EDT

Journey Medical (DERM) Short-Term Debt issuances (2023)

Updated

Journey Medical (DERM) recorded Short-Term Debt issuances of $28 million in FY2023, up 460.0% from $5 million in FY2022.

Analysis

Journey Medical (DERM) Short-Term Debt issuances (2023) Analysis & Trends

  • Per Business Quant data, DERM's Short-Term Debt issuances was $5 million in FY2022 (-28.6%) and $7 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Issuance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 2.28 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Journey Medical 139.94 Mn 38.03 Mn 12.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 28.00 Mn
API Access

Journey Medical Short-Term Debt issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-issuances&ticker=DERM&period=max&api_key=YOUR_API_KEY